CClinicalTrials.gg
RecruitingNCT06406413Updated Jan 14, 2026

Micro-movements in Patients With Prolonged Disorders of Consciousness

An observational study in Consciousness Disorders, sponsored by First Affiliated Hospital of Zhejiang University. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-14.

Sponsored by First Affiliated Hospital of Zhejiang University · Observational

From the registry’s dates

  • Started May 2024; still recruiting 2 years 5 months later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
179
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The goal of this observational study is to learn about the micro-movements in patients with prolonged disorders of consciousness. The main questions it aims to answer are:

Use the neuropsychological paradigm model to monitor micro-movements, assess the patient's remaining level of consciousness and accurately classify it; screen out patients with cognitive-motor dissociation to improve the prognosis of cognitive function; explore the remaining brain function of patients with chronic disorders of consciousness and promote relevant study of neural mechanisms.

Participants will be subjected to consciousness assessment by CRS-r scale, and their micro-movement changes in response to various emotional stimuli will be captured, along with the collection of EEG and MRI data. Follow-up evaluations will be conducted using the CRS-R scale and GOS scale, with a follow-up period of 6 months.

Read the detailed description

In accordance with the inclusion and exclusion criteria, a total of about 178 participants will be recruited, including about 89 confirmed cases of prolonged disorders of consciousness and 89 healthy control subjects (HCs). Utilizing the random split algorithm from the machine learning library sklearn, the dataset will be randomly divided into a training set (70%) and a testing set (30%). General information about the participants such as age, gender, time and location of injury, as well as medical history, family history, medication history, and surgical history will be collected.

Participants will undergo dual-person, multiple assessments using the CRS-R scale to evaluate auditory, visual, motor, speech responsiveness, communication, and arousal levels. Micro-movement changes in response to various emotional stimuli will be collected, along with EEG and MRI data.

Follow-up evaluations will be conducted on all enrolled patients using the CRS-R scale and the GOS scale, with a follow-up period of 6 months.

02

Conditions studied

  • Consciousness Disorders

Keywords

  • disorders of consciousness
  • consciousness disorders
  • micro-movement
  • consciousness
  • Multidimensional paradigm stimulation
03

In context

Consciousness Disorders

236 studies on the registry are indexed under Consciousness Disorders; 102 are open to participants now.

This study's planned enrollment of 179 is above the median of 79 across 86 observational studies indexed under Consciousness Disorders.

Browse Consciousness Disorders studies →

Lead sponsor

First Affiliated Hospital of Zhejiang University is the lead sponsor of 255 studies on the registry; 139 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients are recruited from both general hospitals and rehabilitation hospitals.

Inclusion criteria

  1. Patients with consciousness disorders for more than 28 days following severe brain injury, assessed by the CRS-R scale to meet the criteria for VS or MCS;
  2. Aged between 18 and 80 years;
  3. Stable vital signs;
  4. Voluntary participation of family members with signed informed consent;
  5. Good cooperation, minimal facial and spontaneous activities, no use of antiepileptic or sedative drugs.

Exclusion criteria

Exclusion Criteria:

  1. Locked-in syndrome;
  2. Contraindications for EEG examination;
  3. Contraindications for MRI scanning, such as the presence of internal metallic implants;
  4. Diseases and factors that may affect brain function assessment, such as metabolic disorders, poisoning, shock, etc.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
179 participants (estimated)
Patient registry
No

Groups and cohorts

  • DoC patients

    patients with disorders of consciousness

    Diagnostic Test: micro-movement; electroencephalogram; MRI

  • healthy controls

    healthy participants matched by gender and age

    Diagnostic Test: micro-movement; electroencephalogram; MRI

Interventions

  • Diagnostic testmicro-movement; electroencephalogram; MRI

    micro-movement; electroencephalogram; MRI

06

What researchers measure

Primary outcomes

  1. GOSE score

    GOS-E is an extended version of the Glasgow Outcome Scale (GOS), which was developed to provide a more detailed assessment of patient functionality and quality of life after experiencing such an injury. It has eight categories: Dead, Vegetative State, Lower Severe Disability, Upper Severe Disability, Lower Moderate Disability, Upper Moderate Disability, Lower Good Recovery, and Upper Good Recovery.

    Time frame: six months

Secondary outcomes

  1. CRS-R score

    CRS-R a standardized neurobehavioral assessment measure designed for use in patients with disorders of consciousness. The scale is intended to be used to establish diagnosis, monitor behavioral recovery, predict outcome, and assess treatment effectiveness. The CRS-R consists of 6 subscales designed to assess auditory function, receptive and expressive language, visuoperception, communication ability, motor functions, and arousal level.

    Time frame: six months

07

Study locations

1 of 1 sites recruiting
  • First Affiliated Hospital,Zhejiang University
    Hanzhou, Zhejiang 310003, China
    • Zhuolin He, BA · Contact · hezhuolin@zju.edu.cn · 15990049962
    • Benyan Luo, PhD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06406413
Lead sponsor
First Affiliated Hospital of Zhejiang University
Collaborators
Hangzhou Mingzhou Brain Rehabilitation Hospital, Zhejiang Provincial Armed Police Corps Hospital
Responsible party
Sponsor
First posted
May 9, 2024
Start date
May 1, 2024
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jan 14, 2026

Study contacts

Zhuolin He
Contact
hezhuolin@zju.edu.cn
15990049962
Benyan Luo
Contact
luobenyan@zju.edu.cn

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion